{"id":"W4295817566","doi":"10.1016/j.annonc.2022.07.585","title":"456MO METEOR-1: A phase I study of the safety and efficacy of the protein arginine methyltransferase 5 (PRMT5) inhibitor GSK3326595 in advanced solid tumors","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"Cilag; Army Research Office; Daiichi Sankyo Europe; National Cancer Institute; Ignyta; Institut National Du Cancer; University of Texas MD Anderson Cancer Center; Mereo BioPharma; Plexxikon; AstraZeneca; Genentech; MEI Pharma; Institut Gustave-Roussy; Basilea Pharmaceutica; Deciphera Pharmaceuticals; Astellas Pharma; Cancer Research UK; Springworks Therapeutics; Glenmark Pharmaceuticals; EMD Serono; Flatiron Health; Ascentage Pharma; Aminex Therapeutics; SK Life Science; Syndax Pharmaceuticals; Oregon Health and Science University; Mersana Therapeutics; Tizona Therapeutics; Amgen; Exelixis; Mirati Therapeutics; GlaxoSmithKline; Ribon Therapeutics; Astex Pharmaceuticals; Les Laboratories Pierre Fabre; Novocure; Ipsen; Jazz Pharmaceuticals; National Institutes of Health; Natera; Regeneron Pharmaceuticals; Sanofi; BeiGene; Memorial Sloan-Kettering Cancer Center; Merck KGaA; Gilead Sciences; Symphogen; Boston Biomedical; Pfizer; Celgene; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Oncology; Population; Breast cancer; Anemia; Phases of clinical research; Renal cell carcinoma; Nausea; Cancer; Gastroenterology; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005900505,0.0001241426,0.0003616659,0.00006688451,0.00007239953,0.000001357592,0.0002514226,0.00008377952,0.00001953592],"category_scores_gemma":[0.0001690354,0.00009160987,0.0001122797,0.0003381425,0.0001685549,0.000004008572,0.0002437318,0.0001803252,6.788638e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002467783,"about_ca_system_score_gemma":0.0002355668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008139443,"about_ca_topic_score_gemma":0.0002007274,"domain_scores_codex":[0.9982636,0.0005626391,0.0005562837,0.0002603699,0.0001899965,0.0001671319],"domain_scores_gemma":[0.9990585,0.00005344261,0.0003512146,0.0004003889,0.0001060966,0.00003035315],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00296504,0.001728176,0.0006829072,0.00002743147,0.0001083748,0.000001657166,0.0007766556,0.00648816,0.9628917,0.00003168322,0.00007463605,0.02422358],"study_design_scores_gemma":[0.008215921,0.007841455,0.01549176,0.00002964667,0.00004578718,0.000009212447,0.0008332436,0.00008812506,0.9621423,0.00005812934,0.005129725,0.0001146201],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966195,0.0006710352,0.00001666147,0.001126798,0.0001148414,0.001285785,0.00006020622,0.000002506483,0.000102641],"genre_scores_gemma":[0.9995946,0.00006034001,0.00004118789,0.00009273729,0.00003239255,0.00008570599,0.00001172386,0.00001404022,0.00006726419],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02410896,"threshold_uncertainty_score":0.3735742,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02026020508949061,"score_gpt":0.3406396318417041,"score_spread":0.3203794267522135,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}